0001104659-22-004980.txt : 20220118 0001104659-22-004980.hdr.sgml : 20220118 20220118180109 ACCESSION NUMBER: 0001104659-22-004980 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220113 FILED AS OF DATE: 20220118 DATE AS OF CHANGE: 20220118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Doshi Dipal CENTRAL INDEX KEY: 0001613084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40969 FILM NUMBER: 22536154 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Entrada Therapeutics, Inc. CENTRAL INDEX KEY: 0001689375 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813983399 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6 TIDE STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-305-1825 MAIL ADDRESS: STREET 1: 6 TIDE STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: CycloPorters, Inc. DATE OF NAME CHANGE: 20161104 4 1 tm223204-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-01-13 0 0001689375 Entrada Therapeutics, Inc. TRDA 0001613084 Doshi Dipal C/O ENTRADA THERAPEUTICS, INC. 6 TIDE STREET BOSTON MA 02210 1 1 0 0 President and CEO Common Stock 2022-01-13 4 M 0 10000 1.74 A 184460 D Stock Option (Right to Buy) 1.74 2022-01-13 4 M 0 10000 0 D 2029-05-14 Common Stock 10000 399989 D Consists of (i) 170,067 shares of common stock and (ii) 14,393 shares of restricted common stock issued upon early exercise of stock options. 25% of the shares subject to this option vested and became exercisable on December 31, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter. /s/ Jared Cohen, as Attorney-in-Fact 2022-01-18